Atovaquone and Thrombophlebitis - a phase IV clinical study of FDA data

Summary:

Thrombophlebitis is reported as a side effect among people who take Atovaquone (atovaquone), especially for people who are male, 30-39 old, have been taking the drug for 1 - 6 months also take Myambutol, and have Hiv infection.

The phase IV clinical study analyzes which people have Thrombophlebitis when taking Atovaquone. It is created by eHealthMe based on reports of 5,778 people who have side effects when taking Atovaquone from the FDA, and is updated regularly.

What is Atovaquone?

Atovaquone has active ingredients of atovaquone. eHealthMe is studying from 5,786 Atovaquone users. Check the latest studies of Atovaquone.

What is Thrombophlebitis?

Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot) is found to be associated with 939 drugs and 1,267 conditions by eHealthMe. Check the latest studies of Thrombophlebitis.

On Jul, 11, 2026

5,778 people reported to have side effects when taking Atovaquone.
Among them, 11 people (0.19%) have Thrombophlebitis.

Could Atovaquone cause Thrombophlebitis?

Among these 11 people:

How long have people been on Atovaquone when they have Thrombophlebitis? *

What is the gender of people who have Thrombophlebitis when taking Atovaquone? *

female: 18.18 %
male: 81.82 %

What is the age of people who have Thrombophlebitis when taking Atovaquone? *

What are other drugs people take besides Atovaquone? *

What are other side effects people have besides Thrombophlebitis? *

Acute Kidney Failure: 7 people, 63.64%
Cor Pulmonale Acute (rapid enlargement of the right ventricle of the heart): 7 people, 63.64%
Drug Hypersensitivity: 7 people, 63.64%
Pulmonary Embolism (blockage of the main artery of the lung): 7 people, 63.64%
Fever: 7 people, 63.64%
Renal Tubular Necrosis (death of kidney tubules): 5 people, 45.45%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 3 people, 27.27%
Blood Culture Positive: 2 people, 18.18%
Drug Resistance (reduction in effectiveness of a drug): 2 people, 18.18%
Dyspnea (difficult or laboured breathing): 2 people, 18.18%

What are the existing conditions these people have? *

Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 7 people, 63.64%
Hiv Infection: 7 people, 63.64%
Multiple Myeloma (cancer of the plasma cells): 2 people, 18.18%
Vaginal Infection: 1 person, 9.09%
Urinary Tract Infection: 1 person, 9.09%
Thrombocytopenia (decrease of platelets in blood): 1 person, 9.09%
Rashes (redness): 1 person, 9.09%
Oedema Peripheral (superficial swelling): 1 person, 9.09%
Nausea (feeling of having an urge to vomit): 1 person, 9.09%
Insomnia (sleeplessness): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Atovaquone and have Thrombophlebitis?

- Check whether Thrombophlebitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atovaquone:

Atovaquone (5,786 reports)

Thrombophlebitis treatments and more:

Thrombophlebitis (13,501 reports)

Browse all side effects of Atovaquone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombophlebitis:

Thrombophlebitis (939 drugs)

Browse all the conditions that are associated with Thrombophlebitis:

Thrombophlebitis (1,267 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on atovaquone (the active ingredients of Atovaquone) and Atovaquone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.